Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Patterns (New York, N.Y.)
|
May 5, 2022
A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism
Vanessa Lage-Rupprecht, Bruce Schultz, Justus Dick, et al.
Bioinformatics (Oxford, England)
|
December 21, 2020
The COVID-19 Ontology
Astghik Sargsyan, Alpha Tom Kodamullil, Shounak Baksi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 30, 2023
Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial
C Paola Tello Valverde, Gati Ebrahimi, Mirjam A Sprangers, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors
Upul K Bandarage, Alex M Aronov, Jingrong Cao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2016
Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey
Arja Gerritsen, Marc Jacobs, Inge Henselmans, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2015
Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors
Michael J Boyd, Upul K Bandarage, Hamilton Bennett, et al.
Biorxiv : the Preprint Server for Biology
|
December 31, 2025
An Interactive Brain Atlas of Knowledge
Leon Stefanovski, Konstantin Bülau, Leon Martin, et al.
Journal of Medicinal Chemistry
|
February 16, 2007
Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors
Alex M Aronov, Christopher Baker, Guy W Bemis, et al.
Journal of Medicinal Chemistry
|
October 16, 2009
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control
Alex M Aronov, Qing Tang, Gabriel Martinez-Botella, et al.
Journal of Medicinal Chemistry
|
October 16, 2014
Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability
Anne-Laure Grillot, Arnaud Le Tiran, Dean Shannon, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Patterns (New York, N.Y.)
|
May 5, 2022
A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism
Vanessa Lage-Rupprecht, Bruce Schultz, Justus Dick, et al.
Bioinformatics (Oxford, England)
|
December 21, 2020
The COVID-19 Ontology
Astghik Sargsyan, Alpha Tom Kodamullil, Shounak Baksi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 30, 2023
Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial
C Paola Tello Valverde, Gati Ebrahimi, Mirjam A Sprangers, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors
Upul K Bandarage, Alex M Aronov, Jingrong Cao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2016
Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey
Arja Gerritsen, Marc Jacobs, Inge Henselmans, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2015
Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors
Michael J Boyd, Upul K Bandarage, Hamilton Bennett, et al.
Biorxiv : the Preprint Server for Biology
|
December 31, 2025
An Interactive Brain Atlas of Knowledge
Leon Stefanovski, Konstantin Bülau, Leon Martin, et al.
Journal of Medicinal Chemistry
|
February 16, 2007
Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors
Alex M Aronov, Christopher Baker, Guy W Bemis, et al.
Journal of Medicinal Chemistry
|
October 16, 2009
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control
Alex M Aronov, Qing Tang, Gabriel Martinez-Botella, et al.
Journal of Medicinal Chemistry
|
October 16, 2014
Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability
Anne-Laure Grillot, Arnaud Le Tiran, Dean Shannon, et al.
Page
of 6